The aim of this study was to analyze whether genetic changes of MGMT, IDH1/2 and BRAF occur in PXA or gcGBM and if these genetic changes, respectively their distinct distribution pattern, could be used as molecular markers in the differentiation of these glial tumor entities. This evidence concerns the gene IDH1 and glioma.